Surge in Open Interest Signals Increased Trading Activity for Sun Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd has seen a notable rise in open interest, reaching 79,456 contracts, alongside a trading volume of 125,480 contracts. The stock has outperformed its sector and is trading above key moving averages, reflecting strong market engagement and positive investor sentiment in the pharmaceuticals sector.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the stock. The latest open interest stands at 79,456 contracts, up from the previous 62,143, marking a change of 17,313 contracts or an impressive 27.86% increase. The trading volume for the day reached 125,480 contracts, indicating robust market engagement.In terms of price performance, Sun Pharma has outperformed its sector by 0.96%, with the stock gaining 3.88% over the last two days. Today, it opened with a gain of 2.41% and reached an intraday high of Rs 1,812.7, reflecting a rise of 5.78%. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a strong upward trend.
The pharmaceuticals and drugs sector has also seen a gain of 2.15%, contributing to the overall positive sentiment. Notably, the delivery volume on April 2 has increased by 54.45% compared to the 5-day average, indicating rising investor participation. With a market capitalization of Rs 4,30,093.00 crore, Sun Pharmaceutical Industries continues to maintain a solid position in the large-cap segment. Overall, the notable spurt in open interest underscores the stock's active trading environment today.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
